Clariant Chemicals (India) board proposes relocation of Masterbatches plant
The Board of Directors of Clariant Chemicals (India) have approved the proposal to relocate the Masterbatches plant of the company…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Better than Statins
Even as the statin market faces generic erosion, pharma companies are trying to figure out novel drugs and fixed dose combinations…
’Patient adherence team spending more than doubled from 2009 to 2011’
M Neelam Kachhap speakes to Manish Gupta, Chief Executive Officer, Indegene Lifesystems Bangalore, to know more about the rising…
UKTI signs MoU with ABLE
Will aim at combining UK's heritage and leadership in the area of healthcare and life sciences and India's emerging and thriving…
Competition intensifies as pharma companies race to launch type II diabetes drugs
New Frost & Sullivan report analysis which products will eventually succeed and why, in the race against time
Avesthagen signs license agreement with AvestaDHATM
Through the non-exclusive agreement, Avesthagen stands to earn $30 million over the next decade
Novo Nordisk launches basal insulin for adult patients with type I and type II diabetes
To be available in India soon
US FDA accepts Boehringer Ingelheims supplemental new drug application
To be used for use of dabigatran etexilate mesylate in deep vein thrombosis and pulmonary embolism